Rheumatological manifestations in diabetes mellitus

Current Diabetes Reviews

Volumn 2, Issue 4, 2006, Pages 455-466

  Del Rosso, Angela ^a,b   Matucci Cerinic, Marco ^a   De Giorgio, Francesca ^b   Minari, Chiara ^b   Rotella, Carlo Maria ^a   Seghieri, Giuseppe ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Division of Medicine II   (Italy)

Author keywords

Diabetes mellitus; Diabetic cheiroarthropathy; Diffuse skeletal hyperostosis; Limited joint mobility; Neuropathic arthritis; Osteoporosis

Indexed keywords

ALENDRONIC ACID; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CAPSAICIN; CORTICOSTEROID; DEFLAZACORT; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PREGABALIN; STEROID; TRAMADOL;

ANKYLOSING HYPEROSTOSIS; ARTHRITIS; BED REST; BONE DENSITY; CALCIFICATION; CARPAL TUNNEL SYNDROME; CHONDROCALCINOSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DUPUYTREN CONTRACTURE; ECHOGRAPHY; EXERCISE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GOUT; HUMAN; HUMEROSCAPULAR PERIARTHRITIS; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; JOINT CONTRACTURE; JOINT MOBILITY; MONONEUROPATHY; NERVE COMPRESSION; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOARTHRITIS; OSTEOPENIA; OSTEOPOROSIS; PEYRONIE DISEASE; PHYSIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SPLINT; TARSAL TUNNEL SYNDROME; TENOSYNOVITIS;

EID: 33750952269     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/1573399810602040455     Document Type: Review

References (133)

1. Lundbaeck K. Stiff hands in long term diabetes. Acta Med Scand 1957; 158: 447-51.
2. Pal B, Griffiths ID, Anderson J, Dick WC. Association of limited joint mobility with Duputryen contracture in diabetes mellitus. J Rheumatol 1987; 14: 582-5.
3. Arkkila PE, Kantola IM, Viikari JS. Duputryen's disease: association with chronic diabetic complicartions. J Rheumatol 1997; 24: 153-9.
4. Arkkila PE, Kantola IM, Viikari JS, Ronnemaa T, Vahatalo MA. Duputryen's disease in type I diabetic patients: a five year prospective study. Clin Exp Rheumatol 1996; 14: 59-65.
5. Fernando DJ, Vernidharan J. Limited joint mobility in Sri Lankan patients with non insulin dependent diabetes. Br J Rheumatol 1997; 36, 374-6.
6. Veves A, Sarnow MR, Giurini JM, et al. Differences in joint mobility and foot pressures between black and white diabetic patients. Diabetic Med 1995, 12: 585-9.
7. Rosembloom AL. Limited joint mobility in insulin dependent childhood diabetes. Eur J Ped 1990, 149: 380-8.
8. Duffin AC, Dnaghue KC, Poter M, et al. Limited joint mobility in the hands and feet of adolescent with type 1 diabetes mellitus. Diabetic Med 1999; 16: 125-30.
9. Infante JR, Rosembloom AL, Silverstein JH, Garzarella L, Pollock BH. Changes in frequency and severity of limited joint mobility in children with type I diabetes mellitus between 1976-78 and 1998. J Pediatr 2001; 138: 33-7.
10. Pal B, Anderson J, Anderson J, Dick WC, Griffiths ID. Limitation of joint mobility and shoulder capsulitis in insulin and non insulin dependent diabetes mellitus. Br J Rheumatol 1986; 25: 147-51.
11. Lindsay JR, Kennedy L, Brew Atkinson A, et al. Reduced Prevalence of limited joint mobility in type 1 diabetes in a U.K. clinic population over a 20 - year period. Diabetes Care 2005; 28: 658-61.
12. Aljahlan M, Choy Less K, Toth E. Limited joint mobility in diabetes. Postgrad Mod 1999; 105: 99-106.
13. Brik R, Berant M, Vardi P. The scleroderma-like syndrome of insulin dependent diabetes mellitus. Ann Rheum Dis 1990; 49: 236-7.
14. Gertrner E, Sukerik S, Gladman D, et al. HLA antigen and nailfold capillary microscopy studies in patients with insulin dependent and non-insulin dependent diabetes mellitus and limited joint mobility. J Rheumatol 1990; 17: 1375-9.
15. Jennings AM, Milner PC, Ward JD. Hand abnormalities are associated with the complications of diabetes in type II diabetes. Diabetic Med 1989; 6: 43-7.
16. Fitzcharles MA, Duby S, Waddell RW, Banks E, Kersh J. Limitation of joint mobility (cheiroarthropathy) in adult non insulin-dependent diabetic patients Ann Rheum Dis 1984; 43: 251-4.
17. Schnider SL, Kohn RR. Effects of age and diabetes on the solubility and non enzymatic glycosilation of human skin collagen. J Clin Invest 1981; 67: 1630-5.
18. Lyons TJ, Kennedy I. Non-enzymatic glycosilation of skin collagen in patients with type I (insulin dependent) diabetes mellitus and limited joint mobility. Diabetologia 1985; 28: 2-5.
19. Rosembloom AL, Silverstein JH. Connective tissue and joint disease in diabetes mellitus. Endocrinol Metab Clin North Am 1996; 25: 473-83.
20. Silverstein JH, gordon Pollock BH, Rosembloom AL. Long-term glycemic control influences the onset of limited joint mobility in type I diabetes
21. Kapoor A, Sibbit WL Jr. Contractures in diabete mellitus: the syndrome of limited joint mobility. Semin Arthritis Rheum 1989; 18: 168-80.
22. Berhteim U, Engstrom-Laurent A, Hofer PA, Hhallgren P, Asplund J, Hellstrom S. Loss of hyaluronan in the basement membrane zone of the skin correlated to the degree of stiff hands in diabetic patients. Acta Derm Venereol 2002; 82: 329-34.
23. Eadington DW, Patrick AW, Collier A, Frier BM. limited joint mobility, Duputryen's contracture and retinopathy in type I diabetes: association with cigarette smoking. Diabetic Med 1989, 6 (2): 152-7.
24. Schulte L, Roberts MS, Zimmerman C, Ketler J, Simon LS. A quantitative assessment of limited joint mobility in patients with diabetes: goniometric analysis of upper extremity passive range of motion. Arthr Rheum 1993; 36: 1429-33.
25. Vera M, Suffos R, Carriles M, et al. A study of the respiratory function in insulin-dependent diabetes with and without limited joint mobility. Acta Diabetol Latina 1990; 27: 113-17.
26. Pal B, Daly M. Skin-fold thickness and nailfold capillaries in diabetics: relationship to limited joint mobility and retinopathy. Br J Rheumatol 1987; 26: 153-5.
27. Mitchell WS, Winocour PH, Gush RJ, et al. Skin blood flow and limited joint mobility in insulin-dependent diabetes mellitus. Br J Rheumatol 1989; 28: 195-200.
28. Collier A, Matthews DM, Kellett HA, Clarke BF, Hunter JA. Change in skin thickness associated with cheiroarthropathy in insulin dependent diabetes mellitus. Br Med J Clin Res Ed 1986; 292: 936.
29. Buckingham B, Perejda AJ, Sandborg C, Kershar AK, Uitto J. Skin, joint, and pulmonary changes in type I diabetes mellitus. Am J dis Chil 1986, 140: 420-3.
30. Chaudhuri KR Davidson AR, Morris IM. Limited joint mobility and carpal tunnel syndrome in insulin dependent diabetes. Br J Rheumatol 1989; 28: 191-4
31. Arkkila PE, Kantoila IM, Viikari JS. Limited joint mobility in non insulin dependent diabetic (NIDDM) patients: correlation to control of diabetes, atherosclerotic vascular disease, and other diabetic complications. J Diabetic Complications 1997; 11: 208-17.
32. Frost D, Beischer W. Limited joint mobility in type I diabetic patients. Associations with microangiopathy and subclinical macroangiopathy are different in men and women. Diabetes Care 2001, 24: 95-9.
33. Arkkila PE, Kantola IM, Viikari JS, Ronnemaa T, Vahatalo MA. Limited joint mobility is associated with the presence but not predict the development of microvascular complications in type I diabetes. Diabetic Med 1996; 13: 828-33.
34. McCance DR, Crowe G, Quinn MJ, Smye M, Kennedy L. Incidence of microvascular complications in type I diabetic subjects with limited joint mobility: a 10 year prospective study. Diabetic Med 1993; 10: 807-10.
35. Eaton RP, Sibbitt WL Jr, Harsh A. The effects of an aldose reductase inhibiting agent on limited joint mobility in diabetic patients. JAMA 1985; 253: 1437-40.
36. Eaton RP, Sibbitt WL Jr, Shah VO, et al. A commentary on 10 years of aldose reductase inhibition for on limited joint mobility in diabetes. J Rheumatol 1990; 17: 951-2.
37. Balci N, Balci MK, Tuzuner S. Shoulder adhesive capsulitis and shoulder range motion in type II diabetes mellitus: association with diabetic complications. J Diabetic Complications 1999; 13: 111-129.
38. Fernando DJ, Masson EA, Veves A, Boulton AJ. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulcration. Diabetes Care 1991; 14: 8-11.
39. Benedetti A, Noacco C, Simonatti M, et al. Diabetic trigger finger. N Engl J Med. 1982;306:1552.
40. Ismail AA, Dasgupta B, Tanqueray AB, Hamblin JJ. Ultrasonographic features of diabetic cheiroarthropathy. Br J Rheumatol 1996; 35: 676-7.
41. Yosipovitch G, Yosipovitch Z, Karp M, Mukamel M. Trigger finger in young patients with insulin dependent diabetes J Rheumatol 1990, 17: 951-2.
42. Sibbitt WL Jr, Eaton RP. Corticosteroid responsive tenosynovitis is a common pathway for limited joint mobility in the diabetic hand. J Rheumatol 1997; 24: 931-6.
43. Gamstedt A, Holm-Glad J, Ohlson CG, Sundstrom M, Hand abnormalities are strongly associated with the duration of diabetes mellitus. J Intern Med 1993;234:189-193.
44. Gamstedt A. Hand abnormalities in patient withn NIDDM. Prog Diabetes 1993; 4: 1-6.
45. Noble J, Heathcote JG, Cohen H. Diabetes mellitus in the aetiology of Dupuytren's disease. J Bone J Surg 1984; 66: 322-5.
46. Smith LL, Burnet SP, McNeil JD. Musculoskeletal manifestations of diabetes mellitus. Br J Sports Med 2003; 37: 30-5.
47. Forgàgs S. Bones and Joints in Diabetes Mellitus. The Hague, The Netherlands: Martinus Nijhoff/Akademia Press; 1982.
48. Julkunen H, Heinonen OP, Pyorala K. Hyperostosis of the spine in an adult population: its relationship to hyperglycemia and obesity. Ann Rheum Dis 1971;30:605-612.
49. Daragon A, Mejad O, Czernichow P, et al. Vertebral hyperostosis and diabetes mellitus: a case-control study. Ann Rheum Dis 1995; 54:375-378.
50. Vezyroglou G, Mitropoulos A, Kyriazis N, Antoniadis C. A metabolic syndrome in diffuse idiopathic skeletal hyperostosis. A controlled study. J Rheumatol 1996;23:672-676.
51. Kiss C, Szilàgyi M, Paksy A, Poòr G. Risk factors for diffuse idiopathic skeletal hyperostosis: a case-control study. Rheumatology 2002;41:27-30.
52. Littlejohn GO. Insulin and new bone formation in diffuse idiopathic skeletal hyperostosis. Clin Rheumatol. 1985;4:294-300.
53. Denko CW, Boja B, Moskowitz RW. Growth promoting peptides in osteoarthrosis and diffuse idiopathic skeletal hyperostosis-insulin, insulin-like growth factor-I, growth hormone. J Rheumatol 1994;21:1725-1730.
54. Hansen BC. The metabolic syndrome X. Ann N Y Acad Sci 1999; 892:1-24.
55. Jonathan D, baer s. cervical osteophytes: their significance in ENT practice. J Laryngol Otol 1990; 104: 236-8.
56. Kmucha S, Cravens R. DISH syndrome and its role in dysphagia. Otolaryngol Head Neck Surg 1994; 110:431-6.
57. Laraoche M, Moulinier L, Arlet J, et al. lumbar and cervical stenosis: frequency of the association and the role of ankylosing hyperostsis. Clin Rheum 1992, 11: 533.
58. Charcot JM. Du cerveau ou de la moelle epiniere. Arch Physiol Nom Pathol 1898;1:161-178, 379-99.
59. Sinha S, Munichoodappa CS, Kozak GP. Neuro-arthropathy in diabetes mellitus. Medicine 1972;51:191-210.
60. Sequeira W. The neuropathic joint. Clin Exp Rheumatol 1994;12: 325-37.
61. Bruckner FE, Howell A. Neuropathic joint. Semin Arthritis Rheum 1972;2:47-69.
62. Brower AC, Allman RM. Pathogenesis of the neuropathic joint: neurotraumatic vs. neurovascular. Radiol 1981;139:349-54.
63. Shapiro SA, Stansberry KB, Hill MA, et al. Normal blood flow and vasomotion in the diabetic Charcot foot. J Diabetes Complications 1998; 12:147-53.
64. Aliabadi P, Nikpoor N, Alparslan L Imaging of neuropathic arthropathy. Semin Musculoskelet Radiol. 2003;7:217-25.
65. Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002; 45: 1085-96.
66. Selby P, Young M, Boulton A. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med 1994; 11: 28-31.
67. Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, Donohoe M, Foster AV, Edmonds ME, Boulton AJ. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia. 2001;44:2032-7.
68. Anderson JJ, Woelffer KE, Holtzman JJ, Jacobs AM. Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surg. 2004;43:285-9.
69. Pitocco D, Ruotolo V, Caputo S, et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care 2005;28:1214-5.
70. Vinik A, Mehrabyan A, Colen L, Boulton A. Focal Entrapment Neuropathies in Diabetes, Diabetes Care 2004; 27:1783-7.
71. Wilbourn AJ: Diabetic entrapment and compression neuropathies. In Diabetic Neuropathy. Dyck PJ, Thomas PK, Eds. Philadelphia, Saunders, 1999, pp. 481-508.
72. Becker J, Nora D, Gomes I, et al. An evaluation of gender, obesity, age and diabetes mellitus as risk factors for carpal tunnel syndrome. Clin Neurophys 2002; 113: 1429-34.
73. de Krom M, Kester A, Knipschild P, Spaans F. Risk factors for carpal tunnel syndrome. Am J Epidemiol 1990; 6:1102-10.
74. Kouyoumdjian JA, Zanetta DM, Morita MP. Evaluation of age, body mass index and wrist index as risk factors for carpal tunnel syndrome severity. Muscle Nerve 2002; 25:93-7.
75. Chammas M, Bousquet P, Renard E, et al. Dupuytren's disease, carpal tunnel syndrome, trigger finger and diabetes mellitus. J Hand Surg (Am). 1995;20:109-14.
76. Cagliero E, Apruzzese W, Perlmutter GS, Nathan DM. Musculoskeletal disorders of the hand and shoulder in patients with loskeletal disorders of the hand and shoulder in patients with diabetes mellitus. Am J Med 2002;112:487-90.
77. Kapritskaya Y, Novak C, Mackinnon S. Prevalence of smoking, obesity, diabetes mellitus and thyroid disease in patients with carpal tunnel syndrome. Ann Plast Surg 2002; 48:269-79.
78. Garland H, Moorehouse D. Compressive lesions of the external popliteal (common peroneal) nerve. BMJ 1952; 21:1373-8.
79. Oloff L, Jacobs A, Jaffe S. Tarsal tunnel syndrome: a manifestation of systemic disease. J Foot Surg 1983; 22:302-7.
80. Mulder DW, Lambert EH, Bastron JA, Sprague RG. The neuropathies associated with diabetes mellitus: a clinical and electromyographic study of 103 unselected diabetic patients. Neurology 1961; 11:275-84.
81. Ivins G. Meralgia parethetica, the elusive diagnosis: clinical experience with 14 adult patients. Ann Surg 2000; 232:281-6.
82. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004; 110: 628-38.
83. Ayyar DR, Sharma KR. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetes mellitus. Curr Diab Rep 2004; 4:409-12.
84. Sharma KR, Cross J, Ayyar DR, Martinez-Arizala A, Bradley WG. Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy. Arch Neurol 2002;59:751-7.
85. Vinik AI, Holland MT, LeBeau JM, Liuzzi FJ, Stansberry KB, Colen LB. Diabetic neuropathies. Diabetes Care 1992; 15:1926-75.
86. Umpierrez GE, Stiles RG, Kleinbart J, et al. Diabetic muscle infarction. Am J Med 1996; 101:245-250.
87. Rocca PV, Alloway JA, Nashel DJ. Diabetic muscular infarction. Semin Arthritis Rheum 1993;22:280-86.
88. Silberberg M, Franke EL, Jarrett BS. Aging and osteoarthritis of the human sternoclavicular joint. Am J Pathol 1959;35:851-53.
89. Cimmino M, Cutolo M. Plasma glucose concentration in symptomatic osteoarthritis: a clinical and epidemiological survey. Clin Exp Rheumatol 1990;39:477-82.
90. Horn CA, Bradley JD, Brandt KD, et al. Impairment of osteophyte formation in hyperglycaemic patients with type II diabetes mellitus and knee osteoarthritis. Arthritis Rheum 1992;35:336-42.
91. Lee P, Rooney PJ, Sturrock RD. The etiology and pathogenesis of osteoarthritis: a review. Semin Arthritis Rheum 1974;3:189-218.
92. Forgàcs S. Diabetes mellitus and rheumatic diseases. Clin Rheum Dis 1986, 12: 729-53.
93. Hansen BC. The metabolic syndrome X. Ann N Y Acad Sci 1999; 892:1-24.
94. Hall AP, Barry PE, Dawber TR. The epidemiology of gout and hyperuricemia. A long-term population study. Am J Med 1967; 42:27-37.
95. Mikkelsen WM. The possible association of hyperuricemia and/or gout with diabetes mellitus. Arthritis Rheum 1965;8:853-64.
96. Denis G, Launay MP. Carbohydrate intolerance in gout. Metabolism 1969;18:770-75.
97. Boyle JA, McKiddie M, Buchanan KD. Diabetes mellitus and gout. Blood sugars and plasma insulin responses to oral glucose in normal weight, overweight and gouty patients. Ann Rheum Dis 1969; 28:374-78.
98. Goudy KS, Tisch R. Immunotherapy for the prevention and treatment of type 1 diabetes. Int Rev Immunol 2005;24:307-26.
99. Larsen CE, Alper CA. The genetics of HLA-associated disease. Current Opinion in Immunology 2004,16:660-7.
100. Lam-Tse WK, Batstra MR, Koeleman BP, et al. The association between autoimmune thyroiditis, autoimmume gastritis and type 1 diabetes. Pediatr Endocrinol Rev 2003;1:22-37.
101. Heward J, Gough SC. Genetic susceptibility to the development of autoimmune disease. Clin Sci 1997; 93: 479-91.
102. Wordsworth P. PCR-SSO typing in HLA-disease association studies. Eur J Immunol 1991; 18: 139-46.
103. Martin S, Kardorf J, Schulte B, et al. Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumathoid arthritis. Diabetologia, 1995, 38: 351-5.
104. Binder A, Maddison PJ, skinner P, Kurtz A, Isenberg DA. Sjogren's Syndrome. Association with type-1 diabetes mellitus. Rheumathology 1989, 28: 518-20.
105. Gregorio F, Cristallini S, Santeusanio F, Filipponi P, Fumelli P. Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes? Diabetes Res Clin Pract 1994;23:43-54.
106. Sosa M, Dominguez M, Navarro MC, et al. Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus. J Diabetes Complicat 1996;10:201-205.
107. van Daele PL, Stolk RP, Burger H, et al. Bone density in non-insulin- dependent diabetes mellitus: the Rotterdam Study. Ann Intern Med 1995;122:409-414.
108. Auwerx J, Dequeker J, Bouillon R, Geusens P, Nijs J. Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus. Diabetes 1988;37:8-12.
109. Mathiassen B, Nielsen S, Johansen JS, et al. Long-term bone loss in insulin-dependent diabetic patients with microvascular complications. J Diabetes Complications 1990;4:145-149.
110. Compston JE, Smith EM, Matthews C, Schofield P. Whole body composition and regional bone mass in women with insulin-dependent diabetes mellitus. Clin Endocrinol (Oxf). 1994;41:289-293.
111. Kayath MJ, Dib SA, Vieiaa JG. Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitus. J Diabetes Complications 1994;8:97-104.
112. Forst T, Pfufzner A, Kann P, et al. Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus. Diabetes Med. 1995;12:874-879.
113. Rosenbloom AL, Lezotte DC, Weber FT, et al. Diminution of bone mass in childhood diabetes. Diabetes 1977;26:1052-1055.
114. Tuominen JT, Impivaara O, Puukka P, Rönemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 1999;22:1196-1200.
115. Canalis E. Bone related growth factors. Triangle 1988; 27: 11-19.
116. Bouillon R. Diabetic bone disease: low turnover osteoporosis related to decreased IGF-1 production. Verh K acad Geneeskd Belg 1992; 54: 365-91.
117. Bouillon R. Diabetic bone disease. Calcif Tissue Int 1991;49:155-160.
118. Frazer TE, White NH, Hough S, et al. Alterations in circulating vitamin D metabolites in the young insulin dependent diabetic. J Clin Endocrinol Metab 1981;53:1154-1159.
119. McNair P, Christiansen MS, Madsbad S, et al. Hypoparathyroidismin diabetes mellitus. Acta Endocrinol 1981;96:81-86.
120. Hampson G, Evans C, Petitt RJ, et al. Bone mineral density, collagen type I alpha I genotypes and bone turnover in prenopausal women with diabetes mellitus. Diabetologia 1998; 41: 1314-20.
121. Forsen L, Meyer HE, Midthjell K, Edna TH. Diabetes mellitus and the incidence of hip fracture: Results from the Nord-Trondelag Health Survey. Diabetologia 1999;42:920-925.
122. Schwartz AV, Sellmeyer DE, Ensrud KE, et al. Study of Osteoporotic Features Research Group Older women with diabetes have an increased risk of fracture: A prospective study. J Clin Endocrinol Metab 2001;86:32-38.
123. Nicodemus KK, Folsom AR. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001; 24:1192-1197.
124. Gregg EW, Mangione CM, Cauley JA, et al. Diabetes and incidence of functional disability in older women. Diabetes Care 2002; 25:61-7.
125. Nelson DA, Jacober SJ. Why do older women with diabetes have an increased fracture risk? J Clin Endocrinol Metab 2001; 86: 29-31.
126. Schwartz AV, Hillier TA, Sellmeyer DE, et al. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 2002; 25: 1749-54.
127. Hanlon JT, Landerman LR, Fillenbaum GG, Studenski S. Fall in African American and white community dwelling elderly residents. J Gerontol A Biol Sci Med Sci 2002; 57: M473-8.
128. Bonfanti R, Mora S, Prinster C, Bognetti E, et al. Bone modeling indexes at onset and during the first year of follow-Up in insulin-dependent diabetic children. Calcif Tissue Int 1997;60:397-400.
129. Valerio G, del Puente A, Esposito-del Puente A, Buono P, Mozzillo E, Franzese A. The lumbar bone mineral density is affected by longterm poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res 2002;58:266-272.
130. Campos Pastor MM, Lopez-Ibarra PJ, Escobar-Jimenez F, Serrano Pardo MD, Garcia-Cervigon AG: Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: A prospective study. Osteoporos Int 2000; 11:455-459.
131. Barrett-Connor E, Ensrud KE, Harper K, et al. Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes. Clin Ther 2003;25:919-30
132. Keegan TH, Schwartz AV, Bauer DC, Sellmeyer DE, Kelsey JL; the fracture intervention trial. Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial. Diabetes Care 2004; 27(7):1547-53.
133. Kleerekoper M. Osteoporosis in postmenopausal women with type 2 diabetes. Diabetes Care 2003; 26: 2457-8.